Published in Biomaterials on January 20, 2009
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A (2010) 2.06
Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B Rev (2011) 1.35
Silk-based biomaterials for sustained drug delivery. J Control Release (2014) 0.94
Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights. Crit Rev Ther Drug Carrier Syst (2013) 0.90
Natural and Genetically Engineered Proteins for Tissue Engineering. Prog Polym Sci (2012) 0.87
Silk constructs for delivery of musculoskeletal therapeutics. Adv Drug Deliv Rev (2012) 0.84
Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release. Int J Nanomedicine (2012) 0.84
Clinical translation of controlled protein delivery systems for tissue engineering. Drug Deliv Transl Res (2015) 0.81
Coseeded Schwann cells myelinate neurites from differentiated neural stem cells in neurotrophin-3-loaded PLGA carriers. Int J Nanomedicine (2012) 0.81
Advancing Tissue Engineering: A Tale of Nano-, Micro-, and Macroscale Integration. Small (2015) 0.80
Repair and reconstruction of a resected tumor defect using a composite of tissue flap-nanotherapeutic-silk fibroin and chitosan scaffold. Ann Biomed Eng (2011) 0.75
Silk-fibronectin protein alloy fibres support cell adhesion and viability as a high strength, matrix fibre analogue. Sci Rep (2017) 0.75
Electrospun scaffolds of silk fibroin and poly(lactide-co-glycolide) for endothelial cell growth. J Mater Sci Mater Med (2015) 0.75
Solvent free production of porous PDLLA/calcium carbonate composite scaffolds improves the release of bone growth factors. Oral Maxillofac Surg (2014) 0.75
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release (2005) 2.17
Silk microspheres for encapsulation and controlled release. J Control Release (2006) 1.81
Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release (2008) 1.72
Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A (2006) 1.68
Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A (2004) 1.59
Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials (2006) 1.56
Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45
Silk fibroin as a vehicle for drug delivery applications. J Control Release (2010) 1.40
Silk fibroin spheres as a platform for controlled drug delivery. J Control Release (2008) 1.35
Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm (2004) 1.30
Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst (2007) 1.29
Effect of scaffold design on bone morphology in vitro. Tissue Eng (2006) 1.28
Nondestructive micro-computed tomography for biological imaging and quantification of scaffold-bone interaction in vivo. Biomaterials (2007) 1.24
PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci (2008) 1.23
Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials (2006) 1.22
Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev (2005) 1.22
On the biomedical promise of cell penetrating peptides: limits versus prospects. J Pharm Sci (2008) 1.18
Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials (2007) 1.17
Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release (2007) 1.12
Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to caco-2 monolayers mimics particle uptake. Pharm Res (2002) 1.12
Localized insulin-like growth factor I delivery to enhance new bone formation. Bone (2003) 1.12
Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm (2004) 1.09
Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry (2005) 1.08
Transport of surface-modified nanoparticles through cell monolayers. Chembiochem (2005) 1.08
Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials (2007) 1.06
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine (2005) 1.05
Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res (2003) 1.03
Optimization strategies for electrospun silk fibroin tissue engineering scaffolds. Biomaterials (2009) 1.03
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Adv Drug Deliv Rev (2013) 1.02
Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors. J R Soc Interface (2008) 1.01
Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem J (2004) 0.98
Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res (2003) 0.97
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target (2009) 0.97
Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers. Eur J Pharm Biopharm (2003) 0.97
Amphiphilic dendrimers: novel self-assembling vectors for efficient gene delivery. Angew Chem Int Ed Engl (2003) 0.96
Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases. Pharm Res (2007) 0.95
Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials (2009) 0.95
Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm (2012) 0.94
The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity. Biochemistry (2006) 0.94
DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev (2005) 0.94
Cotton wool-like nanocomposite biomaterials prepared by electrospinning: in vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res B Appl Biomater (2008) 0.93
Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue. Ann Biomed Eng (2007) 0.91
Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity. J Control Release (2011) 0.90
Microparticle-mediated transfection of non-phagocytic cells in vitro. J Drug Target (2002) 0.90
The support of adenosine release from adenosine kinase deficient ES cells by silk substrates. Biomaterials (2006) 0.90
The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. Biomaterials (2009) 0.88
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods (2004) 0.88
Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev (2009) 0.87
Remodeling of tissue-engineered bone structures in vivo. Eur J Pharm Biopharm (2013) 0.87
Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. Langmuir (2008) 0.86
Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur J Pharm Biopharm (2008) 0.86
Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures. AAPS J (2008) 0.86
Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles. J Drug Target (2003) 0.85
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials (2006) 0.85
One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. J Control Release (2005) 0.85
Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production. Ultrason Sonochem (2004) 0.85
Effect of sterilization on structural and material properties of 3-D silk fibroin scaffolds. Acta Biomater (2013) 0.84
Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models. Pharm Res (2004) 0.84
Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. Biomaterials (2003) 0.84
Bone targeting for the treatment of osteoporosis. J Control Release (2011) 0.84
IGF-I and GH stimulate Phex mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized rats. Eur J Endocrinol (2002) 0.82
A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharm Res (2007) 0.82
Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials (2002) 0.81
Reviewing biophysical and cell biological methodologies in cell-penetrating peptide (CPP) research. Crit Rev Ther Drug Carrier Syst (2007) 0.81
Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res (2005) 0.81
On technological and immunological benefits of multivalent single-injection microsphere vaccines. Pharm Res (2002) 0.80
Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. Biophys J (2005) 0.80
An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J Pharm Sci (2003) 0.80
Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells. Pharm Res (2004) 0.80
Hydrogel nerve conduits produced from alginate/chitosan complexes. J Biomed Mater Res A (2007) 0.80
Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58). Biochim Biophys Acta (2005) 0.79
Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). Pharm Res (2004) 0.79
A crystal clear solution for insulin delivery. Nat Biotechnol (2002) 0.79
Design and validation of a novel bioreactor principle to combine online micro-computed tomography monitoring and mechanical loading in bone tissue engineering. Rev Sci Instrum (2010) 0.79
Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide. Chembiochem (2002) 0.79
Immobilisation of GM-CSF onto particulate vaccine carrier systems. Int J Pharm (2004) 0.79
Transfection of a mouse dendritic cell line by plasmid DNA-loaded PLGA microparticles in vitro. Eur J Pharm Biopharm (2004) 0.78
Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling. Biomaterials (2011) 0.78
Biocompatibility and osteoconduction of macroporous silk fibroin implants in cortical defects in sheep. Eur J Pharm Biopharm (2013) 0.78
Ionic liquid versus prodrug strategy to address formulation challenges. Pharm Res (2014) 0.78